Key Findings
- Tumor transcriptomic analysis, with survival evaluation using Caris CODEai, demonstrated that patient-reported stress and
depressive symptoms were associated with distinct ER-specific transcriptional signatures in breast cancer. - These studies demonstrate how transcriptomic and clinico-genomic analyses can identify distinct biological and immune features
in breast cancer, potentially supporting more personalized approaches to risk stratification and therapeutic development.